Invention Grant
- Patent Title: Eslicarbazepine suspension
-
Application No.: US17327203Application Date: 2021-05-21
-
Publication No.: US11318145B2Publication Date: 2022-05-03
- Inventor: Indranil Nandi , Tusharmouli Mukherjee , Dinesh Kumar , Rakesh K. Singh , Saurabh Srivastava
- Applicant: Jubilant Generics Limited
- Applicant Address: IN Noida
- Assignee: Jubilant Generics Limited
- Current Assignee: Jubilant Generics Limited
- Current Assignee Address: IN Noida
- Agency: McNeely, Hare & War, LLP
- Agent William D. Hare, Esq.
- Main IPC: A61K31/55
- IPC: A61K31/55 ; A61K47/26 ; A61K47/14 ; A61K47/38 ; A61K9/00 ; A61K9/10 ; A61K47/22 ; A61K47/10 ; A61K47/42 ; A61K47/36 ; A61K47/02 ; A61K47/12
Abstract:
The present invention relates to oral ready to use liquid pharmaceutical compositions of eslicarbazepine. It also relates to the processes for the preparation of said liquid compositions. The present invention provides liquid compositions of eslicarbazepine with desired technical attributes such as release profile, viscosity, pH, stability, and acceptable organoleptic properties. The prepared compositions are useful in patients having difficulties in swallowing tablets and provide the physician with providing a more convenient and less cumbersome posology.
Public/Granted literature
- US20210275539A1 ESLICARBAZEPINE SUSPENSION Public/Granted day:2021-09-09
Information query
